Thus, lytic agents -- which are more readily available -- continue to play a very prominent role in the management of STEMI. [33] Fibrinolytic therapy can be administered in most centers within 30 ...

Two randomized trials found that intra-arterial urokinase and tenecteplase did not improve functional outcomes after ...

We described the first case reported in the literature of multiple myeloma in a young African woman with Systemic lupus and Sjögren Syndrome. The clinician should consider multiple myeloma in young ...

During this 3-hour window, fibrinolytic therapy and primary PCI have about ... you can't perform primary PCI but you could give a lytic right now, how much time do you have before you lose the ...

Two new trials saw no impact of thrombolytics in reducing disability at 90 days, but some positive signals offer hope.

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Gene therapy involves the introduction of new genes into cells, to restore or add gene expression, for the purpose of treating disease. Most commonly a mutated gene is replaced with DNA encoding a ...